Avivagen Inc VIVXF

Consumer Defensive Farm Products

Avivagen Inc. is a Canada-based life sciences company. The Company is focused on developing and commercializing products for livestock, companion animal and human applications that safely enhances feed intake and supports immune function, thereby supporting general health and performance. The Company’s operations as one segment, products based on OxC-beta Technology. It OxC-beta technology is derived from its discoveries about B-carotene and other carotenoids, compounds that give certain fruits and vegetables their bright colors. OxC- beta Livestock is a proprietary product, an alternative to the antibiotics commonly added to livestock feeds. The product is available for sale in the United States, Mexico, Philippines, Taiwan, New Zealand, Thailand, Australia and Malaysia. It offers OxC-beta to approximately 46.6 million food animals (poultry, swine, and dairy cattle), 133,820 dogs and 4,000 people.

GREY:VIVXF - Post by User

Avivagen Inc

Bullboard Posts

Comment by lovincoalon May 25, 2017 9:52am

207 Views

Post# 26282054

RE:RE:RE:RE:RE:must be close

that is pretty much boilerplate text for any public company in their filings.
A low float is only an issue for a small # of funds/pensions, the <$1 share price and trading on the TSX-V is the real problem. Now one of them has been solved and the second will be soon. If a low public share float was a problem, you'd never have big funds/pensions invest in private companies as there is no public float for them (that is, until they go public).
I think we are going to enjoy things going forward from here. I believe the good news (sales contracts, etc.) starts flowing soon - why release good PR until you could have the bigger buyers able to buy the stock.

Bullboard Posts

NervGen Pharma: Proof that NVG-291 works?